Prosensa's Series B Round

Prosensa raised a round of funding on December 12, 2008.

Prosensa is a biotechnology company focused on the discovery, development and commercialization of RNA-modulating therapeutics. The company targets genetic disorders with a large unmet medical need, w…

Articles about Prosensa's Series B Round: